Spain (ES)

Thin-film microextraction using the metal-organic framework DUT-52 for determining endocrine disrupting chemicals in cosmetics (2022) Gutierrez-Serpa A, Pasan J, Jimenez-Abizanda A, Kaskel S, Senkovska I, Pino V Journal article Large Room Temperature Anomalous Transverse Thermoelectric Effect in Kagome Antiferromagnet YMn6Sn6 (2022) Roychowdhury S, Ochs AM, Guin SN, Samanta K, Noky J, Shekhar C, Vergniory MG, et al. Journal article Hybrid Bloch-Néel spiral states in Mn1.4PtSn probed by resonant soft x-ray scattering (2022) Sukhanov AS, Ukleev V, Vir P, Gargiani P, Valvidares M, White JS, Felser C, Inosov DS Journal article Diagnostic Odyssey in an Adult Patient with Ophthalmologic Abnormalities and Hearing Loss: Contribution of RNA-Seq to the Diagnosis of a PEX1 Deficiency (2022) Munoz-Pujol G, Alforja-Castiella S, Casaroli-Marano R, Morales-Romero B, Garcia-Villoria J, Yepez VA, Gagneur J, et al. Journal article Blood pressure reduction in higher cardiovascular risk patients in the Global SYMPLICITY Registry (2022) Rodriguez O, Mahfoud F, Schmieder R, Schlaich M, Narkiewicz K, Ruilope L, Williams B, et al. Journal article Antidepressant Use and Its Association with 28-Day Mortality in Inpatients with SARS-CoV-2: Support for the FIASMA Model against COVID-19 (2022) Hoertel N, Sanchez-Rico M, Kornhuber J, Gulbins E, Reiersen AM, Lenze EJ, Fritz BA, et al. Journal article Connecting real-world digital mobility assessment to clinical outcomes for regulatory and clinical endorsement–the Mobilise-D study protocol (2022) Mikolaizak AS, Rochester L, Maetzler W, Sharrack B, Demeyer H, Mazzà C, Caulfield B, et al. Journal article Orbital Decay in M82 X-2 (2022) Bachetti M, Heida M, Maccarone T, Huppenkothen D, Israel GL, Barret D, Brightman M, et al. Journal article Risk-adapted modulation through deintensification of cancer treatments: an ESMO classification (2022) Hannoun-Levi JM, Gutierrez C, Polgar C, Strnad V Journal article Maintenance olaparib plus bevacizumab in patients with newly diagnosed advanced high-grade ovarian cancer: Main analysis of second progression-free survival in the phase III PAOLA-1/ENGOT-ov25 trial (2022) González-Martín A, Desauw C, Heitz F, Cropet C, Gargiulo P, Berger R, Ochi H, et al. Journal article